HK1167592A1 - 環十縮酚酸肽化合物及其作為藥物的用途 - Google Patents

環十縮酚酸肽化合物及其作為藥物的用途

Info

Publication number
HK1167592A1
HK1167592A1 HK12103043.7A HK12103043A HK1167592A1 HK 1167592 A1 HK1167592 A1 HK 1167592A1 HK 12103043 A HK12103043 A HK 12103043A HK 1167592 A1 HK1167592 A1 HK 1167592A1
Authority
HK
Hong Kong
Prior art keywords
compounds
medicament
cycloundecadepsipeptide
cycloundecadepsipeptide compounds
Prior art date
Application number
HK12103043.7A
Other languages
English (en)
Inventor
羅蘭．威戈
曼弗雷德．穆特爾
帕特里克．加魯斯特
羅伯特．利塞克
奧利維爾．特平
格雷古瓦．維亞尼奧
瓦萊麗．尼古拉斯
扎諾拉里 勞拉．諾瓦羅利
拉斐爾．克拉布
Original Assignee
帝柏奧研究制藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 帝柏奧研究制藥有限公司 filed Critical 帝柏奧研究制藥有限公司
Publication of HK1167592A1 publication Critical patent/HK1167592A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK12103043.7A 2008-11-06 2012-03-27 環十縮酚酸肽化合物及其作為藥物的用途 HK1167592A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2008002982 2008-11-06
PCT/IB2009/007361 WO2010052559A1 (en) 2008-11-06 2009-11-06 Cycloundecadepsipeptide compounds and use of said compounds as a medicament

Publications (1)

Publication Number Publication Date
HK1167592A1 true HK1167592A1 (zh) 2012-12-07

Family

ID=40795063

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12103043.7A HK1167592A1 (zh) 2008-11-06 2012-03-27 環十縮酚酸肽化合物及其作為藥物的用途

Country Status (21)

Country Link
US (1) US8501683B2 (zh)
EP (1) EP2355837A1 (zh)
JP (1) JP5758806B2 (zh)
KR (1) KR20110093858A (zh)
CN (1) CN102202679B (zh)
AU (1) AU2009312535B2 (zh)
BR (1) BRPI0920502A2 (zh)
CA (1) CA2741829A1 (zh)
CO (1) CO6361943A2 (zh)
CR (1) CR20110284A (zh)
EA (1) EA020896B1 (zh)
EC (1) ECSP11011101A (zh)
HK (1) HK1167592A1 (zh)
IL (1) IL212672A (zh)
MA (1) MA32841B1 (zh)
MX (1) MX2011004881A (zh)
NZ (1) NZ593204A (zh)
TN (1) TN2011000204A1 (zh)
UA (1) UA102414C2 (zh)
WO (1) WO2010052559A1 (zh)
ZA (1) ZA201103752B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
WO2012145426A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
KR20150013152A (ko) * 2012-05-07 2015-02-04 노파르티스 아게 알리스포리비르를 이용한 약동학적 조절
AR090964A1 (es) 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos
WO2014049540A2 (en) * 2012-09-29 2014-04-03 Novartis Ag Cyclic peptides and use as medicines
GB201217560D0 (en) * 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
US11807664B2 (en) 2017-05-12 2023-11-07 Chugai Seiyaku Kabushiki Kaisha Method for producing cyclic organic compound
RU2716706C1 (ru) * 2019-12-04 2020-03-16 Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" Способ получения полимерсодержащей композиции силибина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3851268T2 (de) * 1987-06-19 1995-01-26 Sandoz Ag Zyklische Peptolide.
KR100695611B1 (ko) 2001-05-17 2007-03-14 주식회사 엘지생활건강 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린유도체를 유효성분으로 하는 모발 성장 촉진제
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
EA012650B1 (ru) * 2004-10-01 2009-12-30 Дебиофарм С.А. ПРИМЕНЕНИЕ [D-MeAla]-[EtVal]-ЦИКЛОСПОРИНА ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИИ ГЕПАТИТА С И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ [D-MeAla]-[EtVal]-ЦИКЛОСПОРИН

Also Published As

Publication number Publication date
UA102414C2 (ru) 2013-07-10
IL212672A (en) 2016-10-31
AU2009312535A1 (en) 2011-06-23
MX2011004881A (es) 2011-08-12
WO2010052559A8 (en) 2011-06-09
US8501683B2 (en) 2013-08-06
US20110212057A1 (en) 2011-09-01
CN102202679B (zh) 2014-05-07
CR20110284A (es) 2011-09-19
EA020896B1 (ru) 2015-02-27
EA201170605A1 (ru) 2011-12-30
TN2011000204A1 (en) 2012-12-17
WO2010052559A1 (en) 2010-05-14
EP2355837A1 (en) 2011-08-17
MA32841B1 (fr) 2011-11-01
JP5758806B2 (ja) 2015-08-05
IL212672A0 (en) 2011-07-31
BRPI0920502A2 (pt) 2015-12-22
JP2012507576A (ja) 2012-03-29
CN102202679A (zh) 2011-09-28
ZA201103752B (en) 2012-03-28
NZ593204A (en) 2013-02-22
KR20110093858A (ko) 2011-08-18
ECSP11011101A (es) 2011-10-31
AU2009312535B2 (en) 2015-03-26
CO6361943A2 (es) 2012-01-20
CA2741829A1 (en) 2010-05-14

Similar Documents

Publication Publication Date Title
IL249941A0 (en) Spiro-oxaindole substances and medical preparations containing them
HK1211889A1 (zh) 二氨基吩噻嗪的治療用途
GB0803018D0 (en) Therapeutic compounds and their use
ZA201200054B (en) Therapeutic compounds and compositions
GB0804685D0 (en) Therapeutic compounds and their use
HK1167592A1 (zh) 環十縮酚酸肽化合物及其作為藥物的用途
GB0807609D0 (en) Therapeutic compounds and their use
IL215835A (en) Carboxamide compounds and their use as a drug
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB0817208D0 (en) Therapeutic apsap compounds and their use
HK1160925A1 (zh) 組織蛋白酶 的用途
GB0803054D0 (en) Medicament
IL245577B (en) Dose unit of efdanosone
EP2431365A4 (en) AZETIDINE COMPOUND AND ITS MEDICAL USE
GB0812913D0 (en) Therapeutic compounds and their use
HK1138193A1 (en) Use of a chinese medicine composition
HK1131039A1 (en) Pharmaceutical use of sophoricoside
AP2788A (en) Simalikalactone E and use thereof as a medicament
GB0802128D0 (en) Therapeutic compounds and their use
GB0815134D0 (en) Therapeutic compounds and their use
GB201018615D0 (en) Novel compounds and use thereof as a medicament
GB0821539D0 (en) Therapeutic compounds and their use
GB0913300D0 (en) Therapeutic compounds and their use
HU0800656D0 (en) Effective use of tea-composition
GB0803395D0 (en) Medicament

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171106